Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases

被引：34

作者：

Wu, Ning-hua ^{[1
,2
]}

Ye, Yu ^{[1
]}

Wan, Bin-bin ^{[1
]}

Yu, Yuan-dong ^{[3
]}

Liu, Chao ^{[1
]}

Chen, Qing-jie ^{[1
]}

机构：

[1] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning 437000, Hubei, Peoples R China

[2] Hubei Univ Sci & Technol, Basic Med Coll, Xianning 437000, Hubei, Peoples R China

[3] Hubei Univ Med, Renmin Hosp, Dept Oncol, Shiyan 442000, Hubei, Peoples R China

来源：

MOLECULAR NEUROBIOLOGY | 2021年 / 58卷 / 11期

基金：

中国国家自然科学基金;

关键词：

Sigma-1; receptor; MAM; Neurodegenerative; SIGMAR1; Target drugs; ENDOPLASMIC-RETICULUM; NEUROTROPHIC FACTOR; MOUSE MODEL; PAIN HYPERSENSITIVITY; NEUROPATHIC PAIN; BRAIN PLASTICITY; RAT MODEL; ACTIVATION; PATHWAY; DYSFUNCTION;

D O I：

10.1007/s12035-021-02524-5

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The sigma-1 receptor (Sig-1R) is encoded by the SIGMAR1 gene and is a nonopioid transmembrane receptor located in the mitochondrial-associated endoplasmic reticulum membrane (MAM). It helps to locate endoplasmic reticulum calcium channels, regulates calcium homeostasis, and acts as a molecular chaperone to control cell fate and participate in signal transduction. It plays an important role in protecting neurons through a variety of signaling pathways and participates in the regulation of cognition and motor behavior closely related to neurodegenerative diseases. Based on its neuroprotective effects, Sig-1R has now become a breakthrough target for alleviating Alzheimer's disease and other neurodegenerative diseases. This article reviews the most cutting-edge research on the function of Sig-1R under normal or pathologic conditions and target drugs of the sigma-1 receptor in neurodegenerative diseases.

引用

页码：5649 / 5666

页数：18

共 50 条

[1] Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases
Ning-hua Wu
Yu Ye
Bin-bin Wan
Yuan-dong Yu
Chao Liu
Qing-jie Chen
Molecular Neurobiology, 2021, 58 : 5649 - 5666
[2] Impact of sigma-1 receptor in cardiovascular and neurodegenerative diseases
Fukunaga, Kohji
ACTA PHARMACOLOGICA SINICA, 2013, 34 : 60 - 60
[3] The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
Penke, Botond
Fulop, Livia
Szucs, Maria
Frecska, Ede
CURRENT NEUROPHARMACOLOGY, 2018, 16 (01) : 97 - 116
[4] Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases
Weng, Tzu-Yu
Tsai, Shang-Yi Anne
Su, Tsung-Ping
JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24
[5] Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases
Tzu-Yu Weng
Shang-Yi Anne Tsai
Tsung-Ping Su
Journal of Biomedical Science, 24
[6] Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs
Hayashi, Teruo
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) : 2 - 5
[7] Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen
Lucke-Wold, Brandon P.
Mookerjee, Shona A.
Cavendish, John Z.
Robson, Matthew J.
Scandinaro, Anna L.
Matsumoto, Rae R.
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) : 17 - 29
[8] Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Ryskamp, Daniel A.
Korban, Svetlana
Zhemkov, Vladimir
Kraskovskaya, Nina
Bezprozvanny, Ilya
FRONTIERS IN NEUROSCIENCE, 2019, 13
[9] Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders
Tsai, Shang-Yi A.
Pokrass, Michael J.
Klauer, Neal R.
De Credico, Nicole E.
Su, Tsung-Ping
EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (12) : 1461 - 1476
[10] Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases
Miki, Yasuo
Mori, Fumiaki
Kon, Tomoya
Tanji, Kunikazu
Toyoshima, Yasuko
Yoshida, Mari
Sasaki, Hidenao
Kakita, Akiyoshi
Takahashi, Hitoshi
Wakabayashi, Koichi
NEUROPATHOLOGY, 2014, 34 (02) : 148 - 158

← 1 2 3 4 5 →